Theratechnologies (NASDAQ:THTX) Announces Earnings Results, Beats Estimates By $0.04 EPS

Theratechnologies (NASDAQ:THTX) posted its earnings results on Wednesday. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.04, Yahoo Finance reports. The business had revenue of $22.02 million for the quarter. During the same quarter in the previous year, the firm earned ($0.40) earnings per share. Theratechnologies updated its FY 2024 guidance to EPS.

Theratechnologies Stock Performance

Shares of THTX stock traded down $0.02 during midday trading on Friday, hitting $1.43. 432 shares of the company were exchanged, compared to its average volume of 50,246. Theratechnologies has a 52 week low of $0.88 and a 52 week high of $3.60. The firm’s 50 day moving average price is $1.30 and its two-hundred day moving average price is $1.47.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.